Evidence map›Paper›PMID 38740992›Full record

ArticleNature biotechnology2025

Linking CRISPR-Cas9 double-strand break profiles to gene editing precision with BreakTag.

Gabriel M C Longo, Sergi Sayols, Andriana G Kotini, Sabine Heinen, Martin M Möckel, Petra Beli, Vassilis Roukos

Abstract read
In one paragraph

Article in Nature biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. In vivo systematic detection of the outcomes of CRISPR-Cas9-mediated DNA repair in skeletal muscle stem cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Nanocarrier-mediated CRISPR-Cas delivery: a novel approach against antibiotic-resistant superbugs.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gabriel M C Longo *Institute of Molecular Biology (IMB), Mainz, Germany.ORCID http://orcid.org/0000-0003-2028-1068
Sergi Sayols *Institute of Molecular Biology (IMB), Mainz, Germany.ORCID http://orcid.org/0000-0002-3877-4170
Andriana G KotiniDepartment of Biology, Medical School, University of Patras, Patras, Greece.ORCID http://orcid.org/0000-0001-9148-6015
Sabine HeinenInstitute of Molecular Biology (IMB), Mainz, Germany.ORCID http://orcid.org/0000-0001-5292-9610
Martin M MöckelInstitute of Molecular Biology (IMB), Mainz, Germany.
Petra BeliInstitute of Molecular Biology (IMB), Mainz, Germany.
Vassilis RoukosInstitute of Molecular Biology (IMB), Mainz, Germany. v.roukos@imb-mainz.de.ORCID http://orcid.org/0000-0002-5065-3937

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 393547839Deutsche Forschungsgemeinschaft (German Research Foundation) 402733153Deutsche Forschungsgemeinschaft (German Research Foundation) 455784893Deutsche Forschungsgemeinschaft (German Research Foundation) INST 247/870-1 FUGG
6 · The paper itself

Abstract

Cas9 can cleave DNA in both blunt and staggered configurations, resulting in distinct editing outcomes, but what dictates the type of Cas9 incisions is largely unknown. In this study, we developed BreakTag, a versatile method for profiling Cas9-induced DNA double-strand breaks (DSBs) and identifying the determinants of Cas9 incisions. Overall, we assessed cleavage by SpCas9 at more than 150,000 endogenous on-target and off-target sites targeted by approximately 3,500 single guide RNAs. We found that approximately 35% of SpCas9 DSBs are staggered, and the type of incision is influenced by DNA:gRNA complementarity and the use of engineered Cas9 variants. A machine learning model shows that Cas9 incision is dependent on the protospacer sequence and that human genetic variation impacts the configuration of Cas9 cuts and the DSB repair outcome. Matched datasets of Cas9 and engineered variant incisions with repair outcomes show that Cas9-mediated staggered breaks are linked with precise, templated and predictable single-nucleotide insertions, demonstrating that a scission-based gRNA design can be used to correct clinically relevant pathogenic single-nucleotide deletions.

Indexed as

CRISPR-Cas SystemsDNA Breaks, Double-StrandedGene EditingCRISPR-Associated Protein 9HumansRNA, Guide, CRISPR-Cas SystemsCRISPR-Associated Protein 9RNA, Guide, CRISPR-Cas Systems

Identifiers

PMID38740992
PMCPMC11994453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.